Latest Share Chat

Genedrive Share News (GDR)

Genedrive Information

Buy GDR Shares
Add GDR to Watchlist
Add GDR to Alert

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 5.375

Bid: 5.25

Ask: 5.50

Change: -0.25 (-4.44%)

Spread: 0.25 (4.762%)

Open: 5.625

High: 5.625

Low: 5.375

Prev. Close: 5.625

Last checked at -

IN BRIEF: Genedrive included in Public Health England framework

Mon, 19th Apr 2021 12:46

Genedrive PLC - Manchester-based molecular diagnostics firm - Wins Public Health England deal under Lot 1 of National Microbiology Framework. Lot 1 relates to supply of diagnostic goods and services. "The award of a framework contract is not exclusive to the company, nor a guarantee of orders, however it does allow participating authorities to issue call-off orders for products in the future," Genedrive says.

Current stock price: 73.36 pence, up 9.5% on Monday

Year-to-date change: up 51%

By Eric Cunha; ericcunha@alliancenews.com

More News

2 Dec 2021 10:37

AIM WINNERS & LOSERS: Digitalbox shares surge on earnings outlook

29 Nov 2021 20:22

IN BRIEF: Genedrive shares soar on bid to get Covid test EU approval

29 Nov 2021 15:13

Genedrive submits new Covid-19 test for EU certification

(Sharecast News) - Molecular diagnostics company Genedrive has submitted its new rapid point-of-care molecular Covid-19 test for CE-IVD certification in Europe, it announced on Monday.

16 Nov 2021 14:35

EXECUTIVE CHANGES: Countryside Properties and musicMagpie poach CFOs

9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

9 Nov 2021 15:02

Revenues fall, losses narrow for Genedrive

(Sharecast News) - Near-patient molecular diagnostics company Genedrive reported revenue of £0.7m in its final results on Tuesday, down from £1.1m year-on-year.

2 Nov 2021 16:01

UK earnings, trading statements calendar - next 7 days

29 Sep 2021 18:23

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

29 Sep 2021 13:08

Genedrive gets CE-IVD marking for new system platform

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Wednesday that the new-generation 'Genedrive System' platform, which was developed to support the commercial launch of the 'Genedrive MT-RNR1' ID kit, had now received CE-IVD marking in anticipation of launch in the UK and the European Union.

23 Sep 2021 16:03

Latest Share Chat

Genedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

IN BRIEF: Genedrive included in Public Health England framework

AIM WINNERS & LOSERS: Digitalbox shares surge on earnings outlook

IN BRIEF: Genedrive shares soar on bid to get Covid test EU approval

Genedrive submits new Covid-19 test for EU certification

EXECUTIVE CHANGES: Countryside Properties and musicMagpie poach CFOs

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Revenues fall, losses narrow for Genedrive

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

Genedrive gets CE-IVD marking for new system platform

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Argo gets GBP18 million loan; Genedrive fundraises

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Genedrive to seek CE mark clearance for MT-RNR1 assay

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Genedrive makes progress with Covid-19 test development

Latest Share Chat

Genedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Genedrive included in Public Health England framework

Login to your account

Quickpicks are a member only feature

Login to your account